Company Filing History:
Years Active: 2024-2025
Title: Megan E Neubig: Innovator in Medicinal Chemistry
Introduction
Megan E Neubig is a prominent inventor based in San Diego, California. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors involved in various diseases. With a total of two patents to her name, her work is paving the way for new therapeutic options.
Latest Patents
Megan's latest patents include innovative compounds such as KHK inhibitors, which are defined by specific formulae with variable substituents. Another notable patent focuses on LPA receptor antagonists, which bind to Lysophosphatidic Acid Receptor 1 (LPAR1) and act as antagonists. These compounds have potential applications in treating diseases such as fibrosis, liver diseases like non-alcoholic steatohepatitis (NASH), interstitial lung disease (TLD), and chronic kidney disease (CKD).
Career Highlights
Megan E Neubig is currently associated with Gilead Sciences, Inc., where she continues to advance her research in medicinal chemistry. Her work is characterized by a commitment to developing effective treatments for complex health conditions.
Collaborations
Some of her notable coworkers include Joshua A Kaplan and Brian P Bestvater, who contribute to her innovative research efforts.
Conclusion
Megan E Neubig is a trailblazer in the field of medicinal chemistry, with her patents reflecting her dedication to improving health outcomes through innovative compounds. Her contributions are vital in the ongoing quest for effective treatments for various diseases.